NHS National Generic Pharmaceuticals Transition 2023_1

Published date: 11 January 2023

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Closing: 17 February 2023, 1pm

Contract summary

Industry

Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£104,188,007

Procurement reference

CF-1268300D0O000000rwimUAA

Published date

11 January 2023

Closing date

17 February 2023

Closing time

1pm

Contract start date

1 August 2023

Contract end date

31 January 2025

Contract type

Supply contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1

Offer reference number: CM/PHG/22/5666

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

CM/PHG/22/5666/00 - Transition Products:

CESW 01/08/2023 - 31/01/2024 (6 months)
NWLN 01/08/2023 - 31/01/2025 (18 months)
LSNE 01/08/2023 - 31/05/2024 (10 months)

CM/PHG/22/5666/01 - Orals Oral (plus non-parenteral) Products:

All regions: 01/08/2023 to 31/05/2024 (10 months)

More information

Attachments

Document No. 05a(iii) - Product listing and usage - Oral products#2.xlsx
Document No. 05a(iii) - Product listing and usage - Oral products#2

Document No. 00 - Read Me First Document#2.docx
Document No. 00 - Read Me First Document#2

Document No. 01 - Invitation to offer covering letter#2.docx
Document No. 01 - Invitation to offer covering letter#2

Document No. 02 - Terms of offer#2.doc
Document No. 02 - Terms of offer#2

Document No. 03 - Framework Agreement and Terms and Conditions - With Lots#2.pdf
Document No. 03 - Framework Agreement and Terms and Conditions - With Lots#2

Document No. 05a(i) - Product listing and usage - Transition products#2.xlsx
Document No. 05a(i) - Product listing and usage - Transition products#2

Document No. 05a(ii) - Selectt offer schedule - Transition CM_PHG22_5666_00#2.xml
Document No. 05a(ii) - Selectt offer schedule - Transition CM_PHG22_5666_00#2

Document No. 05a(iv) - Selectt offer schedule - Oral Products#2.xml
Document No. 05a(iv) - Selectt offer schedule - Oral Products#2

Document No. 05b - Selectt offer schedule instructions#2.docx
Document No. 05b - Selectt offer schedule instructions#2

Document No. 06 - Form of offer#2.doc
Document No. 06 - Form of offer#2

Document No. 08 - Confidential information schedule#2.xls
Document No. 08 - Confidential information schedule#2

Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf
Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022

Document No. 04a - Quality Assurance Process.pdf
Document No. 04a - Quality Assurance Process

Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements copy.pdf
Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements copy

Document No. 07a - Quality control technical sheet.pdf
Document No. 07a - Quality control technical sheet

About the buyer

Contact name

sharron Michelle giblin

Address

Rutland house
Runcorn
WA7 2ES
UK

Telephone

+447702417284

Email

sharron.giblin@nhs.net